{"abstract": "A heated auction and back-of-the-envelope math hint that the buyer is overpaying.", "web_url": "https://www.nytimes.com/2016/08/23/business/dealbook/the-flaws-in-pfizers-plan-to-acquire-medivation.html", "snippet": "A heated auction and back-of-the-envelope math hint that the buyer is overpaying.", "lead_paragraph": "Pfizer seems to know something others do not about the biotech company Medivation.", "source": "The New York Times", "multimedia": [], "headline": {"main": "The Flaws in Pfizer\u2019s Plan to Acquire Medivation", "kicker": "Breakingviews", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Medivation Inc", "rank": 3, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Astellas Pharma", "rank": 5, "major": "N"}], "pub_date": "2016-08-22T20:05:15+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By Robert Cyran", "person": [{"firstname": "Robert", "middlename": null, "lastname": "Cyran", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/dcca7dbf-9072-50c6-a62d-162fd6851b1b", "word_count": 376, "uri": "nyt://article/dcca7dbf-9072-50c6-a62d-162fd6851b1b"}